Skip to main content

Dr. James Youssef, MD

Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)

  • Medicare participating

At a glance

Years since graduation
17
In the NPI registry since
2010
Medicare patients seen, 2024
261

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Advanced Heart Failure and Transplant Cardiology Physician primary
    NY license 272255
  • Cardiovascular Disease Physician
    NY license 272255
  • Internal Medicine Physician
    NY license 272255

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Heart Failure & Transplant Cardiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
261
Services billed
584
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes10039
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes7630
Established patient office or other outpatient visit, 30-39 minutes5348
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function2929
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2828
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician2626
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician2626
Nuclear medicine studies of heart muscle at rest and with stress and spect2626
Ct scan of heart structure with contrast2525
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only2120

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 11 companies reported 36 payments worth $4,614 in total to this clinician.

By type
Consulting Fee$3,000
Food and Beverage$1,614

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 14, 2025Alnylam Pharmaceuticals Inc.
Oct 14, 2025
Consulting Fee
AMVUTTRA · Genetic Disease
$3,000

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $124,097 in research payments for these studies, mostly to the institutions running them.

  • APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
    Alnylam Pharmaceuticals Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Heart Failure & Transplant Cardiology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 3, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1417273152. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.